- Home
- SKYH vs BDTX Comparison
SKYH vs BDTX Comparison
Compare SKYH & BDTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SKYH
- BDTX
- Stock Information
- Founded
- SKYH 2017
- BDTX 2014
- Country
- SKYH United States
- BDTX United States
- Employees
- SKYH N/A
- BDTX N/A
- Industry
- SKYH Military/Government/Technical
- BDTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- SKYH Industrials
- BDTX Health Care
- Exchange
- SKYH Nasdaq
- BDTX Nasdaq
- Market Cap
- SKYH 325.2M
- BDTX 132.5M
- IPO Year
- SKYH N/A
- BDTX 2020
- Fundamental
- Price
- SKYH $9.97
- BDTX $2.61
- Analyst Decision
- SKYH Strong Buy
- BDTX Strong Buy
- Analyst Count
- SKYH 3
- BDTX 6
- Target Price
- SKYH $14.83
- BDTX $14.83
- AVG Volume (30 Days)
- SKYH 179.1K
- BDTX 1.2M
- Earning Date
- SKYH 08-12-2025
- BDTX 08-05-2025
- Dividend Yield
- SKYH N/A
- BDTX N/A
- EPS Growth
- SKYH N/A
- BDTX N/A
- EPS
- SKYH N/A
- BDTX 0.09
- Revenue
- SKYH $17,950,000.00
- BDTX $70,000,000.00
- Revenue This Year
- SKYH $122.85
- BDTX N/A
- Revenue Next Year
- SKYH $45.30
- BDTX N/A
- P/E Ratio
- SKYH N/A
- BDTX $28.49
- Revenue Growth
- SKYH 102.32
- BDTX N/A
- 52 Week Low
- SKYH $8.26
- BDTX $1.20
- 52 Week High
- SKYH $14.52
- BDTX $6.75
- Technical
- Relative Strength Index (RSI)
- SKYH 48.84
- BDTX 59.61
- Support Level
- SKYH $9.75
- BDTX $2.43
- Resistance Level
- SKYH $10.04
- BDTX $2.72
- Average True Range (ATR)
- SKYH 0.28
- BDTX 0.17
- MACD
- SKYH 0.09
- BDTX -0.01
- Stochastic Oscillator
- SKYH 71.13
- BDTX 75.77
About SKYH Sky Harbour Group Corporation
Sky Harbour Group Corp is an aviation infrastructure company building a nationwide network of Home-based solutions for business aircraft. The company develops, leases, and manages business aviation hangars across the United States based on its proprietary targeting and acquisition model, targeting airfields with hangar supply and demand imbalances in the markets. Its hangar campuses feature exclusive private hangars and a full suite of dedicated services specifically designed for home-based aircraft.
About BDTX Black Diamond Therapeutics Inc.
Black Diamond Therapeutics Inc is a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer. It is engaged in the discovery and development of small molecule, tumor-agnostic therapies. The company has one pipeline technology platform, namely Mutation-Allostery-Pharmacology, which is targeting mutations in cancer. Its drugs under the pipeline are BDTX-4933 and BDTX-1535.